[go: up one dir, main page]

AU2002349727A1 - Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof - Google Patents

Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof

Info

Publication number
AU2002349727A1
AU2002349727A1 AU2002349727A AU2002349727A AU2002349727A1 AU 2002349727 A1 AU2002349727 A1 AU 2002349727A1 AU 2002349727 A AU2002349727 A AU 2002349727A AU 2002349727 A AU2002349727 A AU 2002349727A AU 2002349727 A1 AU2002349727 A1 AU 2002349727A1
Authority
AU
Australia
Prior art keywords
hepatitis
monoclonal antibodies
binding fragments
virus monoclonal
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002349727A
Other versions
AU2002349727B2 (en
Inventor
Shengxiang Ge
Ying Gu
Zhiqiang He
Shaowei Li
Ningshao Xia
Jun Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen University
Beijing WanTai Biological Pharmacy Enterprise Co Ltd
Original Assignee
Xiamen University
Beijing WanTai Biological Pharmacy Enterprise Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen University, Beijing WanTai Biological Pharmacy Enterprise Co Ltd filed Critical Xiamen University
Priority claimed from PCT/CN2002/000797 external-priority patent/WO2003040187A1/en
Publication of AU2002349727A1 publication Critical patent/AU2002349727A1/en
Assigned to BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD reassignment BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD Request for Assignment Assignors: YANG SHENG TANG COMPANY LIMITED
Application granted granted Critical
Publication of AU2002349727B2 publication Critical patent/AU2002349727B2/en
Assigned to XIAMEN UNIVERSITY, BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD reassignment XIAMEN UNIVERSITY Request for Assignment Assignors: BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002349727A 2001-11-08 2002-11-08 Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof Expired AU2002349727B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN01134643.4 2001-11-08
CN01134643 2001-11-08
PCT/CN2002/000797 WO2003040187A1 (en) 2001-11-08 2002-11-08 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof

Publications (2)

Publication Number Publication Date
AU2002349727A1 true AU2002349727A1 (en) 2003-07-24
AU2002349727B2 AU2002349727B2 (en) 2008-10-16

Family

ID=4672637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349727A Expired AU2002349727B2 (en) 2001-11-08 2002-11-08 Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof

Country Status (9)

Country Link
US (2) US7786264B2 (en)
EP (2) EP2322625B8 (en)
JP (3) JP2005524386A (en)
KR (1) KR101020256B1 (en)
CN (1) CN100339395C (en)
AU (1) AU2002349727B2 (en)
BR (2) BR122015016384B8 (en)
MX (1) MXPA04004321A (en)
WO (1) WO2003040187A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004321A (en) * 2001-11-08 2004-08-11 Yang Sheng Tang Co Ltd Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof.
CN1850855B (en) * 2006-05-26 2012-08-29 厦门大学 Method and composition for immuning or preparing monoclonal antibody
JP5033195B2 (en) * 2006-12-14 2012-09-26 浙江我武生物科技股▲分▼有限公司 Method for the preparation of a standardized serum mixture and its use for measuring the efficacy of allergens
AR070141A1 (en) * 2008-01-23 2010-03-17 Glenmark Pharmaceuticals Sa SPECIFIC HUMANIZED ANTIBODIES FOR VON WILLEBRAND FACTOR
JP5297734B2 (en) * 2008-09-17 2013-09-25 株式会社Nbcメッシュテック Peptide having binding ability to cedar pollen allergen
US8362203B2 (en) * 2009-02-10 2013-01-29 Wayne State University Non-natural peptides as models for the development of antibiotics
AU2011226672B2 (en) 2010-03-12 2015-07-23 Immunogen, Inc. CD37-binding molecules and immunoconjugates thereof
SG193447A1 (en) * 2011-04-01 2013-10-30 Immunogen Inc Cd37-binding molecules and immunoconjugates thereof
CN105693865B (en) 2011-06-01 2020-07-17 厦门大学 Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof
US10183967B2 (en) 2013-02-12 2019-01-22 Bristol-Myers Squibb Company Tangential flow filtration based protein refolding methods
CN105445463A (en) * 2014-09-25 2016-03-30 苏州新波生物技术有限公司 Hepatitis E virus IgG antibody detection kit and preparation method and application thereof
BR112017026027A2 (en) 2015-06-08 2018-08-14 Debiopharm Int Sa anti-cd37 immunoconjugate and anti-cd20 antibody combinations
CN108699144B (en) 2015-08-28 2022-07-19 德彪发姆国际有限公司 Antibodies and assays for detecting CD37
US11278629B2 (en) 2016-11-02 2022-03-22 Debiopharm International, S.A. Methods for improving anti-CD37 immunoconjugate therapy
CN110412267B (en) * 2018-04-28 2023-04-11 洛阳普泰生物技术有限公司 Canine parainfluenza virus monoclonal antibody and application thereof
JP2021525735A (en) 2018-05-30 2021-09-27 デビオファーム インターナショナル, エス. アー. Anti-CD37 immunoconjugate dosing regimen
CN112384530B (en) * 2018-07-10 2024-02-06 国家医疗保健研究所 Epitope peptide of ORF2I protein of hepatitis E virus
WO2020011755A1 (en) * 2018-07-10 2020-01-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for diagnostic purposes
CN109913424B (en) * 2019-03-28 2020-10-27 浙江大学 A kind of human hepatoma cell line comprising hepatitis E virus replicon, application and construction method
GB201904328D0 (en) * 2019-03-28 2019-05-15 Immunocore Ltd Specific binding molecules
CN117730255A (en) * 2021-07-06 2024-03-19 株式会社先端生命科学研究所 Method for detecting hepatitis E virus infection, antigen polypeptide for detecting hepatitis E virus infection, and kit
WO2023174976A1 (en) 2022-03-16 2023-09-21 Universität Zu Lübeck Broadly neutralizing antibodies against hepatitis e virus
CN114957411B (en) * 2022-05-25 2023-08-18 徐州医科大学 A kind of Hepatitis E virus gene C1 type virus ORF2 recombinant protein and its preparation method and application
CN116298305B (en) * 2023-01-03 2024-05-28 郑州大学 Anti-NT 5C1A autoantibody detection method and in-vitro diagnostic kit

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470925A (en) 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4474493A (en) 1982-09-09 1984-10-02 Modular Systems, Inc. Dowel fastener and joints including same
US5885768A (en) 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US6291641B1 (en) * 1988-06-17 2001-09-18 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
US5686239A (en) 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
US5741490A (en) 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5219990A (en) * 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
JP2908107B2 (en) 1992-03-19 1999-06-21 株式会社日立製作所 Solidification material for radioactive waste and method for treating radioactive waste
EP0662133B1 (en) * 1992-09-18 2009-11-18 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
US5736315A (en) 1992-10-21 1998-04-07 National Institute Of Health Methods and compositions for detecting anti-hepatitis E virus activity
JP3919830B2 (en) 1992-11-28 2007-05-30 財団法人化学及血清療法研究所 Anti-feline herpesvirus-1 recombinant antibody and gene fragment encoding the antibody
WO1995008632A1 (en) * 1993-09-24 1995-03-30 The Macfarlane Burnet Centre For Medical Research Limited Immunoreactive antigens of hepatitis e virus
JP3504963B2 (en) * 1993-10-22 2004-03-08 智靖 羅 DNA fragment encoding amino acid sequence of anti-human high affinity IgE receptor monoclonal antibody
JPH09507749A (en) * 1993-12-22 1997-08-12 アボツト・ラボラトリーズ Monoclonal antibodies against hepatitis E virus and methods of using them
US5830636A (en) * 1993-12-22 1998-11-03 Abbott Laboratories HEV orf-2 monoclonal antibodies and methods for using same
JPH09507025A (en) 1993-12-22 1997-07-15 アボツト・ラボラトリーズ HEV orf-2 monoclonal antibodies and methods of using them
US5830635A (en) * 1995-03-31 1998-11-03 Agnello; Vincent Method of detecting hepatitis C virus in tissues
ATE364631T1 (en) 1999-12-01 2007-07-15 Us Gov Health & Human Serv MAIN NEUTRALIZATION SITE OF THE HEPATITIS E VIRUS AND USE OF THIS NEUTRALIZATION SITE IN VACCINATION PROCEDURES AND IN PROCESSES FOR SCREENING FOR NEUTRALIZATION ANTIBODIES
EP1274725B1 (en) * 2000-04-07 2006-06-07 The Government of the United States of America, as represented by The Secretary, Department of Health and Human Services Use of hev polypeptides
CN101367869B (en) 2000-09-30 2012-12-05 北京万泰生物药业股份有限公司 Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
MXPA04004321A (en) 2001-11-08 2004-08-11 Yang Sheng Tang Co Ltd Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof.
JP2010053113A (en) 2008-08-26 2010-03-11 Sadanao Namiki Self-association type magnetic lipid nanoparticles usable for drug delivery and method for producing the same
JP5264792B2 (en) 2010-01-25 2013-08-14 三菱電機株式会社 Plate heat exchanger

Similar Documents

Publication Publication Date Title
AU2002349727A1 (en) Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof
EP2322625B8 (en) Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
IL200608A0 (en) Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto
IL157142A0 (en) Modified antibodies and methods of use
IL158643A (en) Anti-hmg monoclonal antibodies and compositions containing the same
AU2002327164A1 (en) Engineered tetravalent antibodies and methods of use
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
HUP0400284A3 (en) Recombinant tumor specific antibody and use thereof
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU2002332290A1 (en) Recombinant anti-osteopontin antibody and use thereof
AU2002305478A1 (en) Conjugates of reduced antibodies and biomolecules
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
EP1412538A4 (en) Methods for the simultaneous detection of hcv antigens and hcv antibodies
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2002365228A1 (en) Antigen panels and methods of using the same
AUPR546801A0 (en) Recombinant antibodies
AU2002251999A1 (en) Methods and compositions for the construction and use of fusion libraries using computational protein design methods
AU2002305028A1 (en) West nile virus epitopes and uses thereof
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
IL158846A0 (en) A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
AU2002362414A1 (en) Novel molecules of the hkid-1-related protein family and uses thereof
AU2002342858A1 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus